The price band is Rs.205/- to Rs.218/-
Healthcare Global enterprises Limited (HCG),India's leading provider
of Cancer care is entering the capital market with an initial Public
Offering.The IPO consists of a fresh issue upto 11.6 million equity
shares by the company and an offer for sale upto 18.2 million equity
sharess by existing share holders as mentioned in the Red Herring
Prospectus dated 4th march,2016.
The offer is made through the book Building process wherein atleast
|Dr.B.S.Ajai Kumar,Chairman& CEO addressing media.|
Institutional Buyers (QIB's). The Company in consultation with the
investor selling sharehoders & BLRMs,may allocate upto 60% of the
QIB portion to Anchor Investors at the Anchor Investor Price on a
discretionary basis,out of which one third shall be reserved for
domestic mutual funds only.
The Company proposes to utilise the net proceeds of the fresh Issue
towards; 1. Purchase of medical equipment, 2. Investment in IT software
services and hardware, 3.pre payment of debt and 4.General Corporate
The equity shares will be listed in BSE and NSE .The minimum Bid lot
is 65 equity shares and in multiples of 65 equity shares,thereafter.
This venture is purely a Doctor's Driven Enterprise.
Note: The investors are advised to go through the Prospectus
before taking the decision to invest.